KRAS and malignant colon neoplasm: Consistently, the analysis of the TCGA database revealed that SMURF1 is significantly upregulated in colon cancer tissues harboring KRAS mutations, and the high SMURF1 expression is positively associated with poor survival of colon cancer patients.